Categories Earnings

Earnings Summary Of Glenmark Pharmaceuticals Limited For Q4 FY23

Glenmark Pharmaceuticals Limited is a global pharmaceutical company headquartered in Mumbai, India. Established in 1977, the company has grown to become a leading player in the pharmaceutical industry, with a presence in over 80 countries worldwide. Glenmark focuses on developing and manufacturing innovative and affordable pharmaceutical products across various therapeutic areas, including dermatology, respiratory, cardiovascular, oncology, and more. The company’s research and development efforts are directed towards discovering and developing novel drugs and formulations to address unmet medical needs.

  • Glenmark Pharmaceuticals Limited reported Total Income for Q4 FY23 of ₹3,333.50 Crore up from ₹3,126.34 Crore year on year, a growth of 6.6%.
  • Total Expenses for Q4 FY23 of ₹3,024.53 Crore up from ₹2,774.12 Crore year on year, a growth of 9%.
  • Consolidated Net Loss of ₹403.13 Crore, down from profit of ₹172.56 Crore in the same quarter of the previous year.
  • The Earnings per Share is -₹15.18, up from ₹5.51 in the same quarter of the previous year.

Most Popular

Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript

Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah

All you need to know about Antony Waste Handling Cell in one article

Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?

Demystifying the Leading Non-Ferrous Recycling Company of India

“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,

Top